BioAsia Investments is a venture capital firm focused on funding early-stage life sciences, biotechnology, and healthcare companies, aiming to advance cutting-edge medical solutions.

Contact:
575 High Street Suite 201
Palo Alto, California 94301
United States

Phone: 650-688-818
Fax: 650-688-815

Team:
Edgar Engleman, Partner

Website:
http://www.bioasia.com

Company Type:
Venture Capital Firm

Investment Industries:
Biotechnology, Business and consumer products, Computer hardware, Financial services, Healthcare, Industrial and energy products, IT services, Media and entertainment, Medical equipment, Networking, Real estate, Retailing and distribution, Semiconductors, Software, Telecommunications

Investment Stages:
1st round, 2nd round, 3rd round, 4th round and later, Buyout and acquisition, Mezzanine, Pre-IPO, Seed